Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Open-label, Randomised, Controlled Study to Investigate Efficacy and Safety of NNC0365-3769 (Mim8) in Adults and Adolescents With Haemophilia A With or Without Inhibitors

NCT05053139 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT05053139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05053139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Open-label, Randomised, Controlled Study to Investigate Efficacy and Safety of NNC0365-3769 (Mim8) in Adults and Adolescents With Haemophilia A With or Without Inhibitors
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
December 2, 2021
Completion date
December 17, 2024
Enrollment
281 (actual)
Sites
163

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a, haemophilia a with inhibitors